Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (111-120 of 760) with videos related to

Pageof 76
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 21, 2017
Crushed ticagrelor in comatose patients treated with primary percutaneous coronary interventionFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Nature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J Angiolillo
Journal of the American College of Cardiology|January 14, 2017
Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Therapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide Capodanno
JACC. Cardiovascular Interventions|January 21, 2022
Reply: The Effects of Cangrelor on Platelet Aggregation in STEMI Patients: Methodological or Pharmacological Issues?Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Journal of the American College of Cardiology|February 4, 2022
Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?Pascal Vranckx, Dominick J Angiolillo, Marco Valgimigli
Cardiovascular Research|May 15, 2020
Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trialDominick J Angiolillo, Usman Baber, Roxana Mehran
Giornale Italiano Di Cardiologia (2006)|May 22, 2015
[Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines]Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Circulation Journal : Official Journal of the Japanese Circulation Society|March 4, 2010
Basic principles of platelet biology and clinical implicationsDominick J Angiolillo, Masafumi Ueno, Shinya Goto
European Neurology|October 1, 2008
Hypertriglyceridemia and ischemic strokeNader Antonios, Dominick J Angiolillo, Scott Silliman
Pageof 76

Showing results (111-120 of 760) with videos related to

Sort By:
Pageof 76
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 21, 2017
Crushed ticagrelor in comatose patients treated with primary percutaneous coronary interventionFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Nature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J Angiolillo
Journal of the American College of Cardiology|January 14, 2017
Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Therapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide Capodanno
JACC. Cardiovascular Interventions|January 21, 2022
Reply: The Effects of Cangrelor on Platelet Aggregation in STEMI Patients: Methodological or Pharmacological Issues?Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Journal of the American College of Cardiology|February 4, 2022
Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?Pascal Vranckx, Dominick J Angiolillo, Marco Valgimigli
Cardiovascular Research|May 15, 2020
Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trialDominick J Angiolillo, Usman Baber, Roxana Mehran
Giornale Italiano Di Cardiologia (2006)|May 22, 2015
[Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines]Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Circulation Journal : Official Journal of the Japanese Circulation Society|March 4, 2010
Basic principles of platelet biology and clinical implicationsDominick J Angiolillo, Masafumi Ueno, Shinya Goto
European Neurology|October 1, 2008
Hypertriglyceridemia and ischemic strokeNader Antonios, Dominick J Angiolillo, Scott Silliman
Pageof 76